SCHEMBL2491939

SCHEMBL2491939

[CH2]c1ccc(-c2ccccc2)c(-c2ccccc2)c1N(CCCC)CCCC

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRHR1 P34998 2/20 0.38
AR P10275 1/20 0.35
GAA P10253 1/20 0.35
HPGD P15428 1/20 0.35
GCGR P47871 2/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
ATM Q13315 1/20 0.34
PDE4A P27815 1/20 0.34
PDE4B Q07343 1/20 0.34
PDE4C Q08493 1/20 0.34
PDE4D Q08499 1/20 0.34
MAPT P10636 2/20 0.33
NPSR1 Q6W5P4 2/20 0.33
TDP1 Q9NUW8 1/20 0.33
POLB P06746 1/20 0.33
DHFR P00374 1/20 0.33
MAPK1 P28482 1/20 0.33
ADORA1 P30542 1/20 0.33
ELANE P08246 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2493494 0.91 ADORA1 (0.40) CRHR1ADORA1
SCHEMBL2488675 0.84 KDM4E (0.38) ARHPGDGCGRMEN1KMT2A
SCHEMBL2489246 0.76 MAPT (0.39) MEN1KMT2AMAPTTDP1KDM4E
SCHEMBL2492131 0.74 GCGR (0.45) GCGRDHFRPSMB5
SCHEMBL2491466 0.72 LTA4H (0.40) DHFRMAPK1KDM4E
SCHEMBL16559087 0.71 KDM4E (0.41) ARHPGDMEN1KMT2AATM
SCHEMBL2492803 0.71 TLR8 (0.41) HPGDMEN1KMT2AATMMAPT
SCHEMBL2492230 0.70 GCGR (0.38) GAAHPGDGCGRDHFRADORA1
SCHEMBL12983559 0.69 CRHR1 (0.46) CRHR1GAAHPGDMEN1KMT2A
SCHEMBL2491463 0.69 GCGR (0.44) GCGRMAPTDHFRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2380567-B1 MELANIN PRODUCTION INHIBITOR POLA CHEM IND INC (JP) 2019-01-16 EP disclosed
EP-3009123-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2016-04-20 EP disclosed
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2015-11-19 US disclosed
EP-2845587-A2 Melanin production inhibitor Pola Chemical Industries Inc. (JP) 2015-03-11 EP disclosed
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2014-12-11 US disclosed
US-8846012-B2 Melanin production inhibitor POLA CHEMICAL INDUSTRIES INC. (JP) 2014-09-30 US disclosed
EP-2380567-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2011-10-26 EP disclosed
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2011-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, TH CRHR1 208/4885AR 1293/4885GAA 1009/4885
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR TYR, MC1R, F12 CRHR1 192/4885AR 1071/4885GAA 986/4885
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, MC1R CRHR1 189/4885AR 1154/4885GAA 1068/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.